Back to Search
Start Over
68 Ga-FAPI PET/CT Detected Non-PSMA/FDG-Avid Primary Tumor in De Novo Metastatic Prostate Cancer.
- Source :
-
Clinical nuclear medicine [Clin Nucl Med] 2022 Dec 01; Vol. 47 (12), pp. 1108-1111. Date of Electronic Publication: 2022 Aug 16. - Publication Year :
- 2022
-
Abstract
- Abstract: 68 Ga-labeled PET tracer targeting PSMA is a promising diagnostic approach for staging and restating of prostate cancer (PCa), but cases with clinically relevant PCa and false-negative PSMA PET/CT have been reported. In this case, we reported 68 Ga-PSMA, 18 F-FDG, and 68 Ga-FAPI PET/CT findings in a 65-year-old man with de novo metastatic PCa. 68 Ga-FAPI PET/CT detected non-PSMA/FDG-avid primary PCa, consisting with multiparametric MRI findings. The subsequent histopathologic examination confirmed a Gleason 4 + 5 PCa. This case highlighted that 68 Ga-FAPI PET/CT may be a useful imaging modality for primary PCa detection and localization.<br />Competing Interests: Conflicts of interest and sources of funding: none declared.<br /> (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1536-0229
- Volume :
- 47
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Clinical nuclear medicine
- Publication Type :
- Academic Journal
- Accession number :
- 35961368
- Full Text :
- https://doi.org/10.1097/RLU.0000000000004349